Securities Class Action Filed Against Beta Bionics; Deadline November 3
Kaplan Fox says a securities class action involving Beta Bionics, Inc. was filed in federal court. The stated deadline is November 3, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Law firm files class action against Beta Bionics
Schall, Brown & Schwartz said it filed a federal securities class action against Beta Bionics and certain executives over claims tied to the company’s iLet insulin pump and FDA reporting. Investors have until Nov. 3, 2026, to seek appointment as lead plaintiff.
Robbins LLP Urges BBNX Stockholders Who Lost Money Investing in Beta Bionics, Inc. to Contact the Firm for Information About Leading the Class Action
For best results when printing this announcement, please click on link below: Robbins LLP Urges BBNX Stockholders Who Lost Money Investing in Beta Bionics, Inc. to Contact the Firm for Information About Leading the Class Action Shareholder rights law firm Robbins LLP ( ) reminds investors that a class action was filed